Patent and Trademark Office December 10, 2014 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Grant of Interim Extension of the Term of U.S. Patent No. 5,693,323; Recombinant Humanized Monoclonal Antibody (IgG1
The United States Patent and Trademark Office has issued an order granting interim extension under 35 U.S.C. 156(d)(5) for a one- year interim extension of the term of U.S. Patent No. 5,693,323.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.